PRESS RELEASE published on 08/17/2023 at 22:15, 2 years 7 months ago Moderna Clinical Trial Data Confirm Its Updated COVID-19 Vaccine Generates Robust Immune Response in Humans Against Widely Circulating Variants
PRESS RELEASE published on 08/03/2023 at 12:30, 2 years 7 months ago Moderna Reports Second Quarter 2023 Financial Results and Provides Business Updates
PRESS RELEASE published on 07/13/2023 at 13:00, 2 years 8 months ago Moderna to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
PRESS RELEASE published on 07/05/2023 at 13:00, 2 years 8 months ago Moderna Announces Global Regulatory Submissions For Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345
PRESS RELEASE published on 07/03/2023 at 07:00, 2 years 8 months ago Moderna Submits Regulatory Application to the European Medicines Agency for Its Updated COVID-19 Vaccine
PRESS RELEASE published on 06/22/2023 at 22:05, 2 years 8 months ago Moderna Files for FDA Authorization of Its Updated COVID-19 Vaccine
PRESS RELEASE published on 06/05/2023 at 14:00, 2 years 9 months ago Moderna and Merck Announce mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients with High-Risk Stage III/IV Melanoma
PRESS RELEASE published on 06/01/2023 at 22:05, 2 years 9 months ago Moderna to Present at Upcoming Conferences in June 2023
PRESS RELEASE published on 05/30/2023 at 14:00, 2 years 9 months ago Moderna Announces Phase 2 Data on mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, to be Presented at the 2023 ASCO Annual Meeting
PRESS RELEASE published on 05/19/2023 at 13:00, 2 years 9 months ago Phase 1/2 Interim Data on Moderna's mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia (PA), Presented at the 2023 ASGCT Annual Meeting
Published on 03/19/2026 at 07:30, 3 hours 14 minutes ago Tocvan Drone Magnetic Data Strengthens Gold-Silver Targets Across Gran Pilar; Identifies Broad Zones for Expansion Potential
Published on 03/19/2026 at 06:35, 4 hours 9 minutes ago Golden Lake Announces Securityholder Approval of Arrangement with McEwen Inc.
Published on 03/19/2026 at 01:05, 9 hours 39 minutes ago Prospect Ridge Announces Closing of Flow-Through Share Private Placement
Published on 03/18/2026 at 23:45, 10 hours 59 minutes ago Orogen Royalties Announces Private Placement Update
Published on 03/18/2026 at 21:00, 13 hours 44 minutes ago PLDT's Smart Selects Amdocs to Transform Retail Operations with AI-Powered Store Genie
Published on 03/19/2026 at 10:32, 12 minutes ago Berentzen-Gruppe Aktiengesellschaft: JUMA Recharge+ – Berentzen Group launches functional lifestyle drink
Published on 03/19/2026 at 10:30, 14 minutes ago Ulrike Brouzi takes over as Chairwoman of the Supervisory Board of Salzgitter AG
Published on 03/19/2026 at 10:14, 30 minutes ago Pentixapharm Holding AG will publish its financial report for the 2025 fiscal year on March 26, 2026
Published on 03/19/2026 at 10:05, 39 minutes ago Shipsy Launches AgentFleet, an AI Workforce for Logistics Operations
Published on 03/19/2026 at 10:05, 39 minutes ago Villeroy & Boch successfully holds its own in the 2025 financial year despite challenging market conditions
Published on 03/19/2026 at 08:45, 1 hour 59 minutes ago Deezer et Sonos renouvellent et étendent leur partenariat stratégique
Published on 03/19/2026 at 08:45, 1 hour 59 minutes ago Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 3 hours 44 minutes ago bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 3 hours 44 minutes ago bioMérieux obtient le marquage CE IVDR pour deux tests BIOFIRE® SPOTFIRE® afin de renforcer en Europe le diagnostic des infections respiratoires et pharyngées au plus près du patient
Published on 03/19/2026 at 07:00, 3 hours 44 minutes ago Résultats annuels 2025 et nouvelle signature stratégique
